These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2174762)

  • 1. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
    Fujimoto T; Mitsuhashi S
    Chemotherapy; 1990; 36(4):268-76. PubMed ID: 2174762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of fleroxacin, two other quinolones and three board-spectrum beta-lactams using the E-Test.
    Sobottka I; Neumann S; Laufs R
    Chemotherapy; 1994; 40(5):293-8. PubMed ID: 7956451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of S-ofloxacin.
    Neu HC; Chin NX
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1105-7. PubMed ID: 2506805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.
    Jones RN; Hoban DJ
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):49-56. PubMed ID: 8026157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.
    Yamane N; Jones RN; Frei R; Hoban DJ; Pignatari AC; Marco F
    J Chemother; 1994 Apr; 6(2):83-91. PubMed ID: 8077990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501].
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1996 Mar; 49(3):264-72. PubMed ID: 8935122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of DR-3355, an optically active ofloxacin.
    Une T; Fujimoto T; Sato K; Osada Y
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1336-40. PubMed ID: 3195996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
    Amyes SG; Baird DR; Crook DW; Gillespie SH; Howard AJ; Oppenhiem BA; Pedler SJ; Paull A; Tompkins DS; Lawrie SA
    J Antimicrob Chemother; 1994 Nov; 34(5):639-48. PubMed ID: 7706159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS; Ahlén S
    Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
    Chau PY; Leung YK; Ng WW
    Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.
    Tanaka M; Otsuki M; Une T; Nishino T
    J Antimicrob Chemother; 1990 Nov; 26(5):659-66. PubMed ID: 2079448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
    Niculescu E; Wagener H
    Chemioterapia; 1987 Jun; 6(2 Suppl):132-3. PubMed ID: 3509369
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of levofloxacin against gram-positive bacteria.
    Montanari MP; Mingoia M; Marchetti F; Varaldo PE
    Chemotherapy; 1999; 45(6):411-7. PubMed ID: 10567771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.